Glutamine; Metabolic Disorder

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Glutamine; Metabolic Disorder trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04883515

Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients.

Obesity, which has a prevalence at 15% in France, is a major public health concern. Altered glycemic control and irritable bowel syndrome (IBS) are frequently o…

France110 participantsStarted 2023-03-01

Treatment: Oral glutamine supplementation, Oral protein powder supplementation

All recent trials (27 shown)

Not Yet RecruitingNot Applicable

NCT07347613

Long-term Follow-up of Diabetic Patients From the GLUTADIAB Study

Diabetes and related complications, particularly cardiovascular disease, are associated to exacerbated inflammation, which is characterized by an activation int…

France450 participantsStarted 2026-05-01

Treatment: blood sampling

CompletedNot Applicable

NCT04353869

Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications

Experimental data suggest that glutamine catabolism in involved in the activation of macrophages by generating TCA(Tricarboxylic acid) intermediates that promot…

France995 participantsStarted 2020-11-16

Treatment: Bio collection

Glutamine; Metabolic Disorder

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients.

All recent trials (27 shown)

Long-term Follow-up of Diabetic Patients From the GLUTADIAB Study

Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients.

All recent trials (27 shown)

Long-term Follow-up of Diabetic Patients From the GLUTADIAB Study

Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications

Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome

Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced…

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Glutamine Supplement in MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) Syndrome

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

Perioperative Glutamine Supplementation and Cachexia

Glutamine and Insulin Sensitivity in Type I Diabetes

Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II

The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoin…

Effect of Supplementation With Glutamine and Exercise in Women With HIV/AIDS

Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy

Anaplerotic Therapy in Propionic Acidemia